“o. itemList. length” “this. config. text. ariaShown”
“This. config. text. ariaFermé”
The acquisition strengthens WCG’s planning, optimization, clinical and regulatory capabilities.
PRINCETON, New Jersey, December 3, 2020 / PRNewswire / – WCG today announced the acquisition of Trifecta Clinical, a leader identified in generation clinical trial solutions, adding its full InvestigatorSpace communication platform®, virtual education systems and protection documentation services.
The acquisition of Trifecta expands WCG’s diversity of specialized and complementary responses to the ability to connect sites, sponsors and CRO throughout the clinical trial ecosystem.
“With a multitude of facilities that fully integrate clinical trial education and communication, from notification of letters of protection to exchange of regulatory documents, Trifecta adds another size to WCG’s attractive pricing proposition,” Donald A said. Deieso, Ph. D. , Executive Chairman and CEO of WCG. ” This acquisition is part of our efforts to capture strategic opportunities that allow us to expand and our offerings through waiting for the wishes of our customers. We are pleased to be part of a state-of-the-art company like Trifecta and paintings in combination to help sponsors, CROs and clinical study sites to develop the potency and quality of the paints they make on a daily basis. “
Dave Young, Founder and CEO of Trifecta, added: “We are very pleased to be joining WCG, a company that stores our way to improve the clinical trial procedure by offering difficult answers to long-standing problems. Trifecta evolution. Now as a component At WCG, we can help our consumers by proceeding to deliver continuous innovation, based on unprecedented experience.
In the future, Trifecta will become known as WCG Trifecta and will retain its control structure, as well as its headquarters in Los Angeles and its facilities in Indianapolis, Philadelphia and Osaka, Japan.
Trifecta Trifecta is a trusted global leader and spouse with decades of experience in generating clinical trial responses for leading pharmaceutical, biogeneration and clinical studies organizations. From accelerating the start of studies for trials of all sizes to organizing and disseminating critical data on education and protection events, Trifecta offers a fully built-in education, protection and communication platform designed from scratch. Thanks to him, Trifecta is increasing the speed of clinical trials without compromising accuracy. The result? More trials and fewer errors in a total portfolio of studies.
Trifecta provides clinical trial solutions, adding online/on-demand education for scholars, production for online and web-based study meetings, protection letter distribution, site commissioning fabric exchange, and automated exam closures. benefits of gaining the benefits of real-time visibility for clinical trial education, protection and prestige of documentation across your entire portfolio. For more information, visit Trifecta at www. trifectaclinical. com.
WCGWCG is the world’s leading provider of responses that assess the quality and effectiveness of clinical research. Composed of two divisions, the industry’s first central IRB, WCG IRB, and the first organization of clinical facilities, WCG allows biopharmaceutical companies, CRO and establishments to advance the provision of new remedies and remedies to patients, maintaining the highest coverage criteria for human participants. For more information, visit www. wcgirb. com, www. wcgclinical. com or stay with us on Twitter @WCGClinical linkedIn .
Check the content to download the media: http://www. prnewswire. com/news-releases/wcg-acquires-trifecta-a-global-leader-in-clinical-trial-site-communications-301186039. html
WG SOURCE